In patients with chronic heart failure, serum ferritin levels demonstrated a significant weak inverse correlation with the duration of heart failure (r = -0.206, p = 0.03).
Cross-Sectional (n=88)
No
Iron deficiency in chronic heart failure is significantly associated with worse NYHA functional class and longer disease duration, highlighting the potential benefit of routine iron status evaluation in this population.
Estimación del efecto: r -0.206
valor p: p=0.03
BACKGROUND: Chronic heart failure (HF) is one of the conditions commonly seen in the medical outpatient departments, and iron deficiency (ID) has been reported as the commonest nutritional deficiency in these patients. The presence of ID may interfere with the clinical parameters of chronic HF. The relationship between iron status and chronic HF needs more attention and should be given more consideration in the evaluation of patients with chronic HF. AIM: The aim of the study was to determine the relationship, if any, between iron status and clinical/echocardiographic variables in chronic HF. METHODS AND MATERIALS: A cross-sectional descriptive study was carried out at the Lagos University Teaching Hospital (LUTH), Nigeria, where 88 patients with chronic HF were recruited to participate in this study. The participants underwent clinical and laboratory assessments. Iron status was assessed with full blood count parameters; serum ferritin and transferrin saturation (Tsat) and its relationship with clinical parameters among these participants were also studied. RESULTS: No correlations existed between the duration of chronic HF and iron status when compared using Tsat. However, a significant weak negative correlation was observed between the duration of HF and the serum ferritin levels. The clinical characteristics of the HF participants with and without ID were compared. There was no significant difference in the frequency of prior hospitalization in both groups. However, a higher proportion of participants with severe HF (New York Heart Association (NYHA) classes III/IV) (n = 14; 46.7%) were iron-deficient compared to those with moderate chronic HF (NYHA II) (n = 11; 36.7%). This relationship was statistically significant. Left ventricular ejection fraction (LVEF) was similar in the iron-deficient and iron-replete groups (using serum ferritin or Tsat) both when compared as means and when compared after categorizing LVEF as HF with preserved ejection fraction (HFpEF) vs HF with reduced ejection fraction (HFrEF). There was no statistically significant correlation between the severity of ID and LVEF. Conclusion: A spectrum of clinical changes occurs in patients with chronic HF. ID can make these changes more profound and the condition less amenable to standard HF treatments. These patients may therefore benefit from further evaluation for this nutritional deficiency. Laboratory measurements including Tsat and serum ferritin may help in further assessment of select patients with worse and/or non-responsive clinical parameters.
Amaechi et al. (Mon,) conducted a cross-sectional in Chronic Heart Failure (n=88). Iron status assessment was evaluated on Correlation between serum ferritin levels and duration of heart failure (r -0.206, p=0.03). In patients with chronic heart failure, serum ferritin levels demonstrated a significant weak inverse correlation with the duration of heart failure (r = -0.206, p = 0.03).